Related Experiment Video
Updated: Jan 13, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
The journey from repair to replacement in pediatric aortic valve stenosis: a 10-year single-center experience
Guowei Zeng1, Xinjie Zhang1, Longming Huang1
1Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China.
Insights
Pediatric congenital aortic stenosis (AS) patients often need reoperation within 10 years of initial aortic valve (AoV) repair. AoV replacement during reoperation offers better long-term outcomes than repair for these children.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Congenital Heart Disease
Background:
- Congenital aortic stenosis (AS) requires timely intervention.
- Long-term outcomes and reoperation strategies for pediatric AS after initial aortic valve (AoV) repair are not fully understood.
Purpose of the Study:
- To evaluate reintervention outcomes and long-term prognosis in pediatric patients with isolated AS following their initial AoV repair.
- To compare the effectiveness of different reoperation strategies.
Main Methods:
- Retrospective analysis of clinical data from 203 pediatric patients with isolated AS who underwent initial AoV repair (2013-2024).
- Primary outcome: freedom from reoperation.
- Secondary outcomes: freedom from AoV replacement, freedom from moderate or greater AS/aortic regurgitation.
Main Results:
- The 10-year freedom from AoV reoperation rate was 50.9%.
- The 10-year freedom from AoV replacement rate was 62.7%.
- AoV replacement during reoperation showed superior long-term outcomes compared to secondary AoV repair (P=0.001).
Conclusions:
- Initial AoV repair for pediatric AS yields favorable outcomes, but nearly half of patients require reoperation within a decade.
- AoV replacement is associated with better long-term quality of life for reoperations in pediatric AS patients.
Objective:
The optimal reoperation strategy and long-term outcomes of pediatric patients with congenital aortic stenosis (AS) have not been well elucidated. This study aimed to evaluate the reintervention outcomes and long-term prognosis in patients with isolated AS following their initial aortic valve (AoV) repair.
Methods:
A retrospective analysis was conducted on the clinical data of all patients with isolated AS who underwent initial AoV repair between 2013 and 2024. The primary outcome was the rate of freedom from reoperation after the initial procedure and secondary surgeries.
Results:
A total of 203 patients who underwent initial AoV repair were included. The median age at initial surgery was 2.4 (0.6, 4.7) years. The 30-day mortality rate was 0.5% (1/203). The 10-year freedom from AoV reoperation rate was 50.9% (95% CI: 36.2%-65.6%; n = 48/203). The 10-year freedom from AoV replacement rate was 62.7% (95% CI: 46.0%-79.4%; n = 28/203). Among the 48 patients who underwent reoperation, 20 underwent AoV repair and 28 underwent AoV replacement. Patients in the AoV replacement group were older (9.4 ± 4.0 years vs. 6.7 ± 3.6 years, P = 0.022) and had higher body weight (32.2 ± 14.3 kg vs. 22.8 ± 12.1 kg, P = 0.021). The 10-year freedom from AoV reoperation rate after the secondary procedure was 87.9% (95% CI: 73.4%-100.0%; n = 3/45). The 10-year freedom from moderate or greater AS/ aortic regurgitation was 50.2% (95% CI: 30.8%-69.6%; n = 15/45). Compared with secondary AoV repair, AoV replacement was associated with superior long-term outcomes (P = 0.001).
Conclusion:
Favorable outcomes are achieved in patients with AS after initial AoV repair; however, nearly half of the patients may require reoperation within 10 years. For reoperations, AoV replacement is more likely to provide desirable long-term quality of life.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis IV: Nursing Management

